فهرست و منابع پایان نامه فراوانی هپاتیت D در بیماران دارای انتی ژن سطحی هپاتیت B در استان اردبیل
فهرست:
عنوان.................................................................................................................................................صفحه
فصل اول
1-1 مقدمه وبیان مسئله. 1
2-1تعریف واژه‌های کلیدی.. 2
3-1-اهداف و فرضیات.. 2
1-3-1-هدف کلی.. 2
2-3-1-اهداف اختصاصی.. 2
3-3-1-اهداف کاربردی.. 3
4-3-1-فرضیات یا سوالات تحقیق. 3
فصل دوم
1-2- هپاتیت B. 6
1-1-2-خصوصیات ویروس.. 7
2-1-2-پاتو ژنز. 10
3-1-2-عفونت حاد. 10
4-1-2-عفونت مزمن. 11
5-1-2-عوارض بیماری.. 11
6-1-2-غربالگری کارسینوم هپاتو سلولار. 12
7-1-2-پیشگیری.. 12
8-1-2-درمان عفونت مزمن HBV. 13
2-2-ویروس هپاتیت D (HDV) 14
3-2-بررسی متون. 16
1-3-2-بررسی متون در ایران. 16
2-3-2- بررسی متون در جهان. 19
1-3:نوع مطالعه. 24
فصل سوم
2-3:جامعه ی اماری مورد مطالعه. 24
3-3:روش نمونه گیری و جمع اوری اطلاعات.. 24
5-3:روش تجزیه وتحلیل داده ها و بررسی اماری.. 25
6-3:ملاحظات اخلاقی.. 25
فصل چهارم
نتایج.. 27
فصل پنجم
1-5-بحث.. 41
1-5-پیشنهادات.. 50
1-2-5:پیشنهادات پژوهشی.. 50
2 -2-5-پیشنهادات کاربردی.. 50
3-5-محدودیت ها 50
منابع. 52
.
منبع:
1-Zaki H, Darmstadt GL , Baten A, Ahsan CR, Saha SK .Seroepidemiology of hepatitis B and delta virus infection in Bangladesh. J Trop Pediatr .2003;49;371-4
2-Fonseca JC . (hepatitis D) Rev Soc Bras Med Trop 2002: 35:181-90
3-Massarat S, Malekzadeh R, Rezvan H. Hepatitis B in Iran. Arch Iran Med.2000;3;192-201 .
4-Hassanjani-Roshan MR, Taheri H .Frequency of chronic active hepatitis in asymptomatic HBv carriers in Babol, Iran .Arch Iran Med.2002;5;97
5-Jacobson IM, Dienstag jl , Werner BG, Brettler DB,LevinePH, Mushahwar IK.epidemiology and clinical impact of hepatitis D virus infection.hepatology.1995;5;188-91
6-kawai m,feinstone SM, acute viral hepatitis.IN; Mandell GL, bennet je , D olin R, eds.Mandell,,Douglas and benetts principles and practice of infectious disease.5th ed. Churchill livingstone;1999;1287-828
7-toukan AU al –Kandari S. the role of hepatitis D Virus in liver disease in the Middle east.Prog Clin Biol Res.1991;364 ;63-8
8-Ivaniushina VA,Ryzhova EV,Grudinin MP, Katorgina LG,Nikonova AN,Vinogradova EN et al. the frequency of anti bodies against delta virus in patients with HBS positive hepatitis .vopr virusol.1996 ;41;166-9.in Russian.
9- Tapalaga D, Forzani B, Hele C,Paravacini O,Ponzetto A,Theilmann L.prevalance of the hepatitis delta virus in Rumania .hepatogasTroentrology. 1986:33;238-9
10-Chakraborty P,Kailash U,Jain A,Goyal R,Gupta RK,Das BC,et al.sero prevalence of hepatitis D virus in patients with hepatitis Bvirus-related liver disease.indian J MED res2005;122;254-7.
11-Rezvan H Forouzandeh B,Taroyan S, Fadaiee S,Azordegan F .A study on delta virus infectin and its clinical impact in iran. Infection. 1990;18:26-8.
12-Amini S,Mahmoodi MF ,Andalibi S,Solati Aaa.seroepidemiology of hepatitis B,delta and human immune deficiency virus infections in Hamadan province ,Iran ; apopulation based study.J Trop Med Hyg. 1993;96;277-87
13-Torabi S,Ebrahim –poor S,Maljaie H, Naqili B. seroepidemiologic study on hepatitis delta virus among HBSAg positive subjects in Tabriz ,Iran. Urmia Med J. 2002;13;290-7.
14.Gholamreza Roshandel,Shahryar Semanani,Nafiseh Abdolahi.Prevalence of hepatitis D virus infection in HBSAg positive subjects in Golestan province,northeast Iran.Jmicrobial immunal infect;2008;41:227-230
15-Hassanjani Roshan MR ,Beigi AA, Soleimani MJ. Prevalence of Anti-HDV in choronic carrier of HBV in Babol. Babol Med J. 2004;6(21):50-4.
16-Roshandel G. Semnani S, Abdolahi N, Besharat S, et al. Prevalence of Anti-HDV in HBS Ag positive subjecs in Golestan province, northeast Iran.J MICROBIOL IMMUNOL INFECT .2008;41 (3) 227-30.
17-Taghvaei T, Khanlarpor M, Mahdavi Mohammad R ,T irgar Fakher H, Maleki ,Khalilian A. Prevalence of Anti-HDV in HBS Ag positive and its correlative factors in Sari. JMazandaran Unit Med Sci. 2009;18(67):102-6.
18-Jedary Seifi ,Sabouri Ghannad M. A study of HDV in HBS Ag positive patients in Tabriz, Northwestern Iran .hepato MON. 2010 ;10(2):110-5.
19-Habibi F, Mokhtari H, Gazerani M, Roshani Zaferanloo N. THE Prevalence of Anti-HDV in HBS Ag positive patients .MED Sci J Islamic Azad Univ- Mashhad Branch.2000:5(3):61-7.
20-Ataei B, Kalantari H, Soleimani S, Javadi A, Adibi P, Yaran M, et al.delta hepatitis infection in patient with chronic hepatitis B infection in Isfahan. IRAN.P 2003 .Clin microbial infect. 2009:15 s586.
21- Zahedi MJ, Darvish- Moghaddam S, Zareei H. Clinical impact and frequency of delta hepatitis infection in patient with chronic hepatitis B infection in Southern provice of iran (Kerman).Iran J Virol 2010;3 :1-6.
22-Taghavi sa,S edighi SH, Mehrabani D, Khademolhosseini F.Hepatitis D in chronic active hepatitis B:PREVALENCE,liver enzymes and histopathology –an epidemiological study in Shiraz, southern iran, 2003-2004.hepat mon .2008:8:248-51.
23-Al Traif I,Ali A, Dafalla M, Al Tamimi W, Qassem L. Prevalence of Anti-HDV in HBS Ag positive IN Saudi Arabia. Ann Saudi Med. 2004;24 :343-4.
24-Nair S, Perillo RP, Hepatitis B and D IN:Zakim D, Boyer TD, EDITORS.Hepathology.4th ed.Philadelphia WB Saunders;2003.p.959-1010.
25-Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Lankarani KB. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008;8(4):281–94
26-Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000;3(4):192-201. [AIM
27-Zuckerman JN., Zuckerman AJ. THE epidemiology of hepatitis B. Clin liver Dis 1999;3:176-87.
28-Ott MJ,Aruda M. hepatitis B vaccine. J Pediatr Health care 1999:13:211-6.
29-centers for Disease Control and Prevention .Sexually transmitted disease treatment guideline 2002.MMWR RECOMM rep 2002;51 (RR-6):1-78.
30-Alizade M,Hooshang A,Alavian SM, Jafari kh,. Prevalence of HBsAg ,HCV Ab,HIV –Ab in west of iran (Hamadan province).J microbial immunol infect.2010 :43 :519-23.
31-Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection .clin microbial REV. 1999;12:351-66.
32-Kane MA.Clements j. HUD. Hepatitis B .in:disease control priorities in developing countries. A WORLD BANK BOOK(Eds Jamisor D.T. Mosley W.H. Measham ,A.R. AND BOBADILLA, j.l. oxford university press NEW YORK,1993:3:321-330.
33-Viral hepatitis B .accessed September
17,2003,at:http://www.cdc.gov/ncidod/disease/hepatitis/ b/Bserology.htm.
34-Lok A,Heathcote EJ, Hoofnagle JH.Managment of hepatitis B: summary recommendations of a workshop. Gastroentrology 2001:120:1828-1853.
35-Maddrey WC. Hepatitis B:An important public health issue.J Med virol 2000;61:362-366.
36-Befeler AS .Di Bisceglie AM. Hepatitis B. Infect Dis Clin North AM 2000 :14:617-32.
37- Hepatitis B Vaccination –United State, 1982-2002.MMWR Morb WKLY Rep 2002;51:549-52,563.
38-Rosina F,Saracco G,Rizzetto M,Risk of post transfution infection with the hepatitis delta virus.N Engl J Med 1985;6:312:1488-1491.
39-http://en.wikipedia. org
40-Michael P.Curry sanjiv chopra acute viral,hepatitis mandell,douglas and bennet principle and poactice of infection disease.churchill livingstone, Elsevier;2010.vol.3p.1584/1603
41-Heiner Wede Meyer,Manns MP. Epidemioloy,pathogenesis and management ofHDV .Nat Rew Gasteroenterol Hepatal 2010;7:31-40.
42-Viana S,Parana R,Moreira RC, et al.high prevalence of HBV AND HDV in the western Brazilian Amazon .AM J Top Med .hyg.2005.73(4):808-14
43-S.K.Tan ,M. Dimitro Kakis ,S.Mangalam.C.G. lopez, B.G.Ooi .prevalence of HDV in Malaysia:1989:30:34-37
44-Timothy J.S., Paolo R., Mary H. ,Anita J, munter J. The increasing prevalence of HDV infection in south London. Kings College hospital ,Denmark Hill ,London .UK.2008:80:277-282
45-Foroutan H, Nemati A, Nasiri M, Ghofrani H, Keivani H,,Prevalence HDV in various groups with HBV infection in Tehran ,IMAM KHOMEINI HOSPITAL. Department of Gastroenterology ,Tehran University of Medical Sciences. Vol 22.2. 2008:.pp.93-97.
46-Tajbakhsh E, Abbasian B. Esmaeili A, Behjati M.Seroprevalence of anti-HDV Ab and socioepidemiological characteristics among HBsAg positive blood donor in shahrekord.Hepat MON 2011;11(2) :130-131.
47-Bahcecioqlu IH, Aygun C, Gozel N ,Poyrazoglu OK, Bulut Y , Yalniz M. prevalence of HDV in Chronic hepatitis B pationts in eastern Turkey :firat university ,Medical School ,Elazig ,Turkey.J VIRAL hepat 2011:18(7):518-24.
48-Zaidi G, Idress M, Ahmed malik F, Amin I, Shahid M, YOUNAS S,Hussain R,Awan Z,.P THE Prevalence of Anti-HDV in HBS Ag positive patients In largest province of Pakistan .virology journal 2010 ,7:283.
49-Zanelli AR, Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824–7.
50-Amini N,Alavian SM,Kabir A,Saiedi Hosseini SY,Aalaei-andabili H.Clinical features and seroepidemiology of anti –HDV In patients with chronic HBV in iran:a meta –analysis .HepatMon. 2011;11(12):960-967..
.